Exploratory study evaluating the relationships between perinatal adversity, oxidative stress, and infant neurodevelopment across the first year of life
- PMID: 38153909
- PMCID: PMC10754429
- DOI: 10.1371/journal.pgph.0001984
Exploratory study evaluating the relationships between perinatal adversity, oxidative stress, and infant neurodevelopment across the first year of life
Abstract
Early childhood adversity increases risk for negative lifelong impacts on health and wellbeing. Identifying the risk factors and the associated biological adaptations early in life is critical to develop scalable early screening tools and interventions. Currently, there are limited, reliable early childhood adversity measures that can be deployed prospectively, at scale, to assess risk in pediatric settings. The goal of this two-site longitudinal study was to determine if the gold standard measure of oxidative stress, F2-Isoprostanes, is potentially a reliable measure of a physiological response to adversity of the infant and mother. The study evaluated the independent relationships between F2-Isoprostanes, perinatal adversity and infant neurocognitive development. The study included mother-infant dyads born >36 weeks' gestation. Maternal demographic information and mental health assessments were utilized to generate a perinatal cumulative risk score. Infants' development was assessed at 6 and 12 months and both mothers and infants were assayed for F2-isoprostane levels in blood and urine, respectively. Statistical analysis revealed that cumulative risk scores correlated with higher maternal (p = 0.01) and infant (p = 0.05) F2-isoprostane levels at 6 months. Infant F2-isoprostane measures at 2 months were negatively associated with Mullen Scales of Early Learning Composite scores at 12 months (p = 0.04). Lastly, higher cumulative risk scores predicted higher average maternal F2-isoprostane levels across the 1-year study time period (p = 0.04). The relationship between perinatal cumulative risk scores and higher maternal and infant F2-isoprostanes at 6 months may reflect an oxidative stress status that informs a sensitive period in which a biomarker can be utilized prospectively to reveal the physiological impact of early adversity.
Copyright: © 2023 Gateau et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The authors have read the journal’s policy and have the following competing interests: PL is an employee of Simms/Mann Institute & Foundation (https://www.simmsmanninstitute.org). PL is also an employee of Keck School of Medicine of USC (https://keck.usc.edu/). This does not alter our adherence to PLOS policies on sharing data and materials. There are no patents, products in development or marketed products associated with this research to declare.
Figures
Similar articles
-
Association of Perceived Maternal Stress During the Perinatal Period With Electroencephalography Patterns in 2-Month-Old Infants.JAMA Pediatr. 2019 Jun 1;173(6):561-570. doi: 10.1001/jamapediatrics.2019.0492. JAMA Pediatr. 2019. PMID: 30958515 Free PMC article.
-
The association between prenatal F2-isoprostanes and child wheeze/asthma and modification by maternal race.Free Radic Biol Med. 2022 Aug 20;189:85-90. doi: 10.1016/j.freeradbiomed.2022.07.008. Epub 2022 Jul 19. Free Radic Biol Med. 2022. PMID: 35863687 Free PMC article.
-
Maternal Early Life Adversity and Infant Stress Regulation: Intergenerational Associations and Mediation by Maternal Prenatal Mental Health.Res Child Adolesc Psychopathol. 2023 Dec;51(12):1839-1855. doi: 10.1007/s10802-022-01006-z. Epub 2022 Dec 12. Res Child Adolesc Psychopathol. 2023. PMID: 36508054 Free PMC article.
-
Urinary 8-isoprostane as a biomarker for oxidative stress. A systematic review and meta-analysis.Toxicol Lett. 2020 Aug 1;328:19-27. doi: 10.1016/j.toxlet.2020.04.006. Epub 2020 Apr 19. Toxicol Lett. 2020. PMID: 32320775
-
Induction of labour at or beyond 37 weeks' gestation.Cochrane Database Syst Rev. 2020 Jul 15;7(7):CD004945. doi: 10.1002/14651858.CD004945.pub5. Cochrane Database Syst Rev. 2020. PMID: 32666584 Free PMC article.
Cited by
-
Maternal oxidative stress throughout pregnancy and early childhood neurodevelopment at different stages: insights from a prospective cohort study.BMC Med. 2025 Aug 6;23(1):463. doi: 10.1186/s12916-025-04297-3. BMC Med. 2025. PMID: 40770336 Free PMC article.
-
Oxidative stress as a potential mechanism linking gestational phthalates exposure to cognitive development in infancy.Neurotoxicol Teratol. 2024 Nov-Dec;106:107397. doi: 10.1016/j.ntt.2024.107397. Epub 2024 Oct 1. Neurotoxicol Teratol. 2024. PMID: 39362385
-
Experiences of multiple psychosocial stressors and associations with oxidative stress biomarkers during pregnancy.Free Radic Biol Med. 2025 Jun;233:70-76. doi: 10.1016/j.freeradbiomed.2025.03.036. Epub 2025 Mar 24. Free Radic Biol Med. 2025. PMID: 40139413
-
Proposed Physiological Mechanisms Underlying the Association between Adverse Childhood Experiences and Mental Health Conditions: A Narrative Review.Children (Basel). 2024 Sep 12;11(9):1112. doi: 10.3390/children11091112. Children (Basel). 2024. PMID: 39334644 Free PMC article. Review.
References
-
- Felitti VJ, Anda RF, Nordenberg D, Williamson DF, Spitz AM, Edwards V, et al. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study. Am J Prev Med. 1998;14(4):245–58. doi: 10.1016/s0749-3797(98)00017-8 - DOI - PubMed
-
- Shonkoff JP, Garner AS, Health CoPAoCaF, Committee on Early Childhood Ao, and Dependent Care, Pediatrics SoDaB. The lifelong effects of early childhood adversity and toxic stress. Pediatrics. 2012;129(1):e232–46. - PubMed
-
- Bellis MA, Hughes K, Ford K, Ramos Rodriguez G, Sethi D, Passmore J. Life course health consequences and associated annual costs of adverse childhood experiences across Europe and North America: a systematic review and meta-analysis. Lancet Public Health. 2019;4(10):e517–e28. doi: 10.1016/S2468-2667(19)30145-8 - DOI - PMC - PubMed
-
- Waters H, Graf M. The costs of chronic disease in the US. Santa Monica, CA: The Milken Institute. 2018.
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous